Phase 2 Autism Spectrum Disorder Trial, Recruiting NCT06951854 Sponsor: Neuroventi Inc. Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Phase 2 Autism Spectrum Disorder Trial, Recruiting

NCT06951854
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Children who are between 6 and 15 years old (inclusive) at the time of signing the consent form
  • Children who have been formally diagnosed with Autism Spectrum Disorder (ASD) according to the current standard diagnostic guidelines (DSM-5), meaning they show persistent difficulties with social communication and interaction, as well as restricted or repetitive behaviors, interests, or activities

Who may not be able to join:

  • Children who weigh less than 16 kg (about 35 lbs) or more than 70 kg (about 154 lbs)
  • Children who have a serious mental health condition other than autism that could affect their ability to take part in the trial
  • Children who have a history of brain disease, neurological conditions, or seizures/epilepsy that are not fully controlled by medication or surgery (note: children with a history of simple febrile seizures — fever-related seizures — may still be considered at the doctor's discretion)
  • Children who have severe problems with blood flow in the arteries or heart (confirm with trial site)
  • Children who have experienced, or currently experience, symptoms such as delusions or hallucinations
  • Children who have a digestive or stomach condition (such as active peptic ulcers) or have had stomach/intestinal surgery that might affect how the body absorbs the study medication (note: children who have had a simple appendix removal or hernia surgery may still be considered)
  • Children who displayed serious self-harming or aggressive behavior that needed medical attention during the screening period, as judged by the doctor
  • Children who have sensory conditions such as being born with hearing loss

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +82 025405630

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Neuroventi Inc.
Registry
ClinicalTrials.gov
Start date
1 April 2025
Est. completion
1 September 2025

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Change from baseline in the composite scores of the major domains of the Korean Vineland Adaptive Behavior Scales-II (K-Vineland-II) at Week 8 after administration.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov